|
1
|
Sun L, Zou LX, Han YC, Wu L, Chen T, Zhu
DD and Hu P: A20 overexpression exerts protective effects on
podocyte injury in lupus nephritis by downregulating UCH-L1. J Cell
Physiol. 234:16191–16204. 2019. View Article : Google Scholar
|
|
2
|
Mu Q, Zhang H, Liao X, Lin K, Liu H,
Edwards MR, Ahmed SA, Yuan R, Li L, Cecere TE, et al: Control of
lupus nephritis by changes of gut microbiota. Microbiome. 5:732017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Miranda-Hernández D, Cruz-Reyes C, Angeles
U, Jara LJ and Saavedra MA: Prognostic factors for treatment
response in patients with lupus nephritis. Reumatol Clin.
10:164–169. 2014.(In English, Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rees F, Doherty M, Grainge MJ, Lanyon P
and Zhang W: The worldwide incidence and prevalence of systemic
lupus erythematosus: A systematic review of epidemiological
studies. Rheumatology (Oxford). 56:1945–1961. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hogan J and Appel GB: Update on the
treatment of lupus nephritis. Curr Opin Nephrol Hypertens.
22:224–230. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Okpechi IG, Gcelu A and Ameh OI: Lupus
nephritis: A simplified approach to diagnosis and treatment in
South Africa. South African Medical J. 105:1071–1074. 2015.
View Article : Google Scholar
|
|
7
|
Chan TM: Treatment of severe lupus
nephritis: The new horizon. Nat Rev Nephrol. 11:46–61. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Malvar A, Pirruccio P, Alberton V, Lococo
B, Recalde C, Fazini B, Nagaraja H, Indrakanti D and Rovin BH:
Histologic versus clinical remission in proliferative lupus
nephritis. Nephrol Dial Transplant. 32:1338–1344. 2015. View Article : Google Scholar
|
|
9
|
Ren HJ, Sun YL and Yuan B: Chinese patent
medicine Bailing capsule for treating lupus nephritis: A protocol
for systematic review and meta-analysis. Medicine (Baltimore).
98:e170412019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu H and Li S: Pharmacological effects of
Bailing capsule and its application in lung disease research.
Zhongguo Zhong Yao Za Zhi. 35:2777–2781. 2010.(In Chinese).
PubMed/NCBI
|
|
11
|
Li S and Wang L: Clinical observation on
the therapeutic effect of Corbrin Capsule in the treatment of lupus
nephritis. Chin Commun Doctors. 33:61–62. 2017.(In Chinese).
|
|
12
|
Zhou L, Zhang B, Yao C and Liao A:
Clinical research of Bailing capsules on change of cellular
immunity in lupus nephritis. Chin Pharmacist. (4): 289–290.
2004.(In Chinese).
|
|
13
|
Bai XM, Li H, Li XD and Li Y: Clinical
study on corbrin capsules combined with cyclophosphamide in
treatment of lupus nephritis. Drugs Clin. 34:1181–1184. 2019.(In
Chinese).
|
|
14
|
Li XY, Li FX and Li B: Clinical study on
corbrin capsules combined with leflunomide and prednisone in
treatment of lupus nephritis. Drugs Clin. 34:154–158. 2019.(In
Chinese).
|
|
15
|
Higgins JP and Green S: Cochrane handbook
for systematic reviews of interventions: Cochrane Book Series. The
Cochrane Collaboration; 2008
|
|
16
|
Liu T, Xu QE, Zhang CH and Zhang P:
Occupational exposure to methylene chloride and risk of cancer: A
meta-analysis. Cancer Causes Control. 24:2037–2049. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lau J, Ioannidis JP and Schmid CH:
Quantitative synthesis in systematic reviews. Ann Intern Med.
127:820–826. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Feng RN, Zhao C, Sun CH and Li Y:
Meta-analysis of TNF 308 G/A polymorphism and type 2 diabetes
mellitus. PLoS One. 6:e184802011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ma E, Wang H, Guo J, Tian R and Wei L: The
association between the rs11196218A/G polymorphism of the TCF7L2
gene and type 2 diabetes in the Chinese Han population: A
meta-analysis. Clinics (Sao Paulo). 70:593–599. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Seagroatt V and Stratton I: Bias in
meta-analysis detected by a simple, graphical test. Test had 10%
false positive rate. BMJ. 316:469–471. 1997.
|
|
21
|
He Y, Huang JP, Wu RY and Tan F:
Observation of clinical effect of Bailing capsule combined with low
molecular weight heparin for the treatment of lupus of nephritis.
Asia Pacific Tradit Med. 9:207–208. 2013.(In Chinese).
|
|
22
|
Liu DM, Wang CH and Li XP: Clinical
analysis of 65 cases of lupus nephritis treated by Bailing capsule.
Chin Commun Doctors. 21. 2006.(In Chinese).
|
|
23
|
Wang GH, Su XD and Wu Y: Clinical study on
Corbrin Capsules combined with prednisone in treatment of lupus
nephritis. Drugs Clin. 33:2372–2376. 2018.(In Chinese).
|
|
24
|
Wang JB: Clinical effect of boling capsule
combined with prednisone in the treatment of lupus nephritis SLEDAI
scoring analysis. Chin J Mod Drug Appl. 121–122. 2019.(In
Chinese).
|
|
25
|
Wang XY, Wang GJ, Zhang XX, Gong YN, Li
YS, Ma S, Xiao J and Zhao ZZ: Clinical study on Bailing capsules
combined with tacrolimus in treatment of lupus nephritis. Drugs
Clin. 32:1065–1069. 2017.(In Chinese).
|
|
26
|
Wu G: Methyprednisolone with Bailing
capsule in treatment of lupus nephritis. J Medical Forum. 28:38–39.
2007.(In Chinese).
|
|
27
|
Yang ZH, Liu B, Lu J, Hou XX and Yin J: A
multicenter prospective study of the effect of Bailing capsules on
clinical efficacy and infection rate in the patients with lupus
nephritis. Heilongjiang Med J. 28:1205–1208. 2015.(In Chinese).
|
|
28
|
Zhu PJ, Ke SS and Xu F: Effect of Bailing
capsules on interleukin-2, complement and infection rate in
patients with lupus nephritis. Chin J Mod Appl Pharm. 33:364–368.
2015.(In Chinese).
|
|
29
|
Xu DD: Observation on the efficacy of
boling capsule combined with tacrolimus in the treatment of lupus
nephritis. Mod Diagn Treat. 29:2888–2890. 2018.
|
|
30
|
Wang WX: Study on the combination of
boling capsule and tacrolimus in the treatment of lupus nephritis.
Chin J Mod Drug Appl. 12:112–113. 2018.
|
|
31
|
Shu Q, Tan F, Huang LH and Peng J: Effect
of Bailing capsules on macrophage function by regulating miR- 127
expression in lupus nephritis patients. Tradit Chinese Drug Res
Clin Pharmacol. 30:733–738. 2019.(In Chinese).
|
|
32
|
Feng D: The correlation analysis of urine
microalbumin /urine creatinine and 24 h urine proteinquantification
in patients with chronic nephritis. Laborat Med Clin.
14:1942017.(In Chinese).
|
|
33
|
Zhang H and Ge X: Significance of Cys C,
BUN and sCr level detection in assessment of early renal damage of
acute glomerulonephritis. J Hainan Med Univ. 22:447–449. 2016.(In
Chinese).
|
|
34
|
Gladman DD, Ibañez D and Urowitz MB:
Systemic lupus erythematosus disease activity index 2000. J
Rheumatol. 29:288–291. 2002.PubMed/NCBI
|
|
35
|
Wang BL, Li QY and Huang WL: Assessment of
renal injury degree in patients with nephritis by β 2-m, AIb, IgG,
and α 1-m. J Radioimmunol. 14:91–93. 2001.
|
|
36
|
Szulińska M, Skrypnik D, Ratajczak M,
Karolkiewicz J, Madry E, Musialik K, Walkowiak J, Jakubowski H and
Bogdański P: Effects of endurance and endurance-strength exercise
on renal function in abdominally obese women with renal
hyperfiltration: A prospective randomized trial. Biomed Environ
Sci. 29:706–712. 2016.PubMed/NCBI
|
